A Prospective, Double-blind, Randomized Study to Compare Efficacy of Two Etanercept Regimens (REUMATOCEPT; Versus ENBREL) for Treatment of Rheumatoid Arthritis.
Phase of Trial: Phase III
Latest Information Update: 01 Mar 2013
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Sponsors EMS Sigma Farma
- 01 Mar 2013 Planned End Date changed from 1 Jun 2012 to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 01 Mar 2013 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov.
- 18 Jul 2011 New trial record